Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eprotirome in Heterozygous Familial Hypercholesterolaemia (AKKA)
NCT01410383Phase 3Terminated
- Sponsor
- Karo Healthcare AB
- Start
- Oct 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of eprotirome in heterozygous familial hypercholesterolemia (HeFH), sponsored by Karo Healthcare AB. Started Oct 2011; status: terminated.
02
Drugs
eprotirome
03
Conditions
heterozygous familial hypercholesterolemia (HeFH)
Beyond the preview
Go deeper on NCT01410383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01410383.